PainChek Ltd Corporate Presentation Transcript

Mar 20, 2024 / 12:00AM GMT
Release Date Price: A$0.260938 (-1.85%)
Matt Wright
NWR Communications - IR

Welcome back to the NWR Virtual Health Care Conference. Next up, we have the CEO and Managing Director of PainChek, Philip Daffas. Philip has held senior business leadership positions, building global medical device businesses in the cardiovascular diabetes, hearing impairment, and pathology sectors.

He has roles with Cochlear, including European sales and marketing director based in London. (inaudible) promote to Cochlear's Vice President, Global Marketing in Sydney. Philip's earlier experience was in Europe with Pfizer, Eli Lilly, and Roche Diagnostics where he was a global marketing director in the diabetes care business unit based in Manheim, Germany.

PainChek is the world's first regulatory cleared medical device for the assessment of pain, enabling best practice pain

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot